New Journey Begins on the Eighth Day of the First Lunar Month: Pooling Efforts for Development – Guizhou Tiandi Pharmaceutical Holds General Management Meeting

On February 24th, the eighth day of the first lunar month on the Chinese calendar, amidst the festive atmosphere of commencing work, Guizhou Tiandi Pharmaceutical Co., Ltd. held its 2026 General Management Meeting. All personnel from the company's functional departments and section chiefs and above from the production department attended the meeting. Mr. Liu Zhengchao, the company's Chairman and General Manager, presided over the meeting and delivered an important speech, setting the direction and charting the course for the new year's work.

Review and Summary: Drawing Strength from Reflection

The meeting began with an in-depth review of the year-end summaries submitted by various departments. Chairman Liu Zhengchao pointed out that the summaries submitted this time showed positive changes: the content was objective and truthful, directly addressing problems without ambiguity, and work plans were highly targeted, reflecting the team's dedication and progress. The avoidance of taking undue credit and the emphasis on teamwork demonstrated good professional conduct. Simultaneously, the Chairman also noted a lack of willingness to put forward opinions and suggestions in the summaries, reflecting the need for the company to further foster an organizational atmosphere of frank communication and courage to speak up.

Assessing the Situation: Facing Challenges with Clarity

Considering the industry landscape of 2026, Chairman Liu Zhengchao comprehensively analyzed the complex situation facing the company. He pointed out that overcapacity and involution in the industry have become the norm, as has stringent supervision in the pharmaceutical industry. The situation regarding the phasing out of outdated production capacities and enterprises is very severe. Market uncertainties have increased significantly, making company profit expectations unpredictable. Against the backdrop of high-quality development, the transformation and upgrading of traditional industries are extremely challenging. As an established enterprise primarily focused on low-end products, Tiandi Pharmaceutical suffers from insufficient capital reserves and lagging new product research and development, continually compressing its living space. With the frequent introduction of new national policies, if all employees fail to keep pace with the times, update their cognition, and ensure technological transformations comply with laws and regulations, the company's development path can be described as walking on thin ice.

Setting the Direction: Seeking Breakthroughs through Persistence

Facing these challenges, Chairman Liu Zhengchao clarified the work guidelines and strategic deployment for 2026 and the period ahead. 

In terms of operational management: The company must persistently adhere to the basic strategy of prioritizing orders and cash flow, with the bottom line being the company's survival. Efforts must be made to firmly secure orders and strive for full-capacity production. It is essential to ensure a continuous cash flow and enhance capital turnover efficiency. Comprehensively promoting cost reduction and efficiency enhancement is necessary to strengthen market adaptability and competitiveness.

 In terms of internal management: First, we must solidify the foundation of production quality, striving with all our might to ensure compliance with laws and regulations, thereby providing strong backing for operational management. Second, we need to optimize human resource management, focusing on enhancing the professional competence of grassroots personnel, and resolutely abolish or merge departments and positions afflicted by overstaffing to achieve a lean organization. Third, we must strengthen internal control with financial management at its core, keeping a close watch on key departments that directly impact profitability to truly realize cost reduction and efficiency gains. Fourth, we should improve the incentive mechanism to ensure that hard workers are rewarded and opportunists have nowhere to hide, fostering a positive and pragmatic working atmosphere.

Guardians Together: Forging the Future through Endeavor

Concluding the meeting, Chairman Liu Zhengchao issued a call to all employees: We must jointly guard our enterprise. He emphasized that only through the collective dedication, earnest work, and focused effort of every employee can we ensure the company's continued normal operation. Heads of all departments should lead their teams with feeling and commitment, leading by example to become managers worthy of the trust of both employees and the company. All employees must engage in continuous learning and constantly improve their cognitive abilities to adapt to the rapid changes of the times and the market. 

'Our shared peaceful existence can only be safeguarded through our collective guardianship,' Chairman Liu Zhengchao's words were emphatic. 'As long as the company continues to survive and develop, we will undoubtedly have a bright future. We have reason to believe that by facing challenges head-on and maintaining the courage and resilience to overcome all difficulties, we will surely carve a path for ourselves in the global market and create a living space belonging to Tiandi Pharmaceutical!' 

This meeting served not only as a gathering for everyone after the 2026 Spring Festival holiday but also unified thinking, clarified the direction, and consolidated strength for the new year's work. Attendees expressed that they would translate the spirit of the meeting into every specific task with greater clarity of mind, firmer resolve, and a more pragmatic work style, striving tenaciously for the company's survival and future. In the new year, Guizhou Tiandi Pharmaceutical is ready to embark on its journey!